Adenosine Receptor Agonists Increase the Inhibition of Platelet Function by P2Y<sub>12</sub> Antagonists in a cAMP- and Calcium-Dependent Manner
We have shown previously that platelet activity can be lowered through the simultaneous inhibition of P2Y<sub>12</sub> receptor and activation of adenosine receptors (AR). This work explores this concept by testing the antiplatelet potential of nine AR agonists in combination with P2Y<...
Main Authors: | Nina Wolska, Hassan Kassassir, Boguslawa Luzak, Cezary Watala, Marcin Rozalski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/13/8/177 |
Similar Items
-
Adenosine Receptor Agonists Exhibit Anti-Platelet Effects and the Potential to Overcome Resistance to P2Y<sub>12</sub> Receptor Antagonists
by: Nina Wolska, et al.
Published: (2019-12-01) -
Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy
by: Nina Wolska, et al.
Published: (2019-11-01) -
Adenosine Receptor Agonist HE-NECA Enhances AntithromBotic Activities of Cangrelor and Prasugrel In Vivo by Decreasing of Fibrinogen Density in Thrombus
by: Dawid Polak, et al.
Published: (2021-03-01) -
How Are Adenosine and Adenosine A<sub>2A</sub> Receptors Involved in the Pathophysiology of Amyotrophic Lateral Sclerosis?
by: Akihisa Mori, et al.
Published: (2021-08-01) -
Development of a Radiofluorinated Adenosine A<sub>2B</sub> Receptor Antagonist as Potential Ligand for PET Imaging
by: Marcel Lindemann, et al.
Published: (2020-04-01)